Direct to consumer advertising of drugs in Europe

British Medical Journal

Volumn 335, Issue 7619, 2007, Pages 526-

  Magrini, Nicola ^a   Font, Maria ^b  

^a Local Health Authority of Modena   (Italy)

^b Verona Local Health Authority   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ROFECOXIB; DRUG;

CONFIDENTIALITY; CONSUMER; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; EDITORIAL; EUROPE; EVIDENCE BASED PRACTICE; HEART INFARCTION; HUMAN; INFORMATION DISSEMINATION; INTERNET; NEW ZEALAND; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH; RISK BENEFIT ANALYSIS; UNITED STATES; ADVERTIZING; ORGANIZATION AND MANAGEMENT; PATIENT EDUCATION; PUBLIC RELATIONS;

ADVERTISING; DRUG INDUSTRY; EUROPE; INTERPROFESSIONAL RELATIONS; PATIENT EDUCATION; PHARMACEUTICAL PREPARATIONS; PRIVATE SECTOR; PUBLIC SECTOR;

EID: 34548840583     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39310.506308.AD     Document Type: Editorial

References (0)